TSRO
Tesaro Inc
stockNASDAQ

Latest News

Oct 20, 2026

03:49 PM EDTAnaptysBio quickly drops amid hearing on GSK/Tesaro contract breach · Seeking Alpha

Oct 19, 2026

02:18 PM EDTJemperli (dostarlimab) Approved in the U.S. as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer · GlobeNewswire Inc.

Sep 21, 2026

04:15 PM EDTAnaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update · GlobeNewswire Inc.

Tesaro Inc is an oncology-focused biopharmaceutical company. It focuses on developing treatments for cancer.